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Background: In the present study, we investigated the ability of polyethylene glycol (PEG)
functionalized gold nanoparticles to function as nonviral vectors in the transfection of different
cell lines, comparing them with commercial lipoplexes.
Methods: Positively‐charged gold nanoparticles were synthesized using polyethylenimine
(PEI) as a reducing and stabilizer agent and its cytotoxicity was reduced by its functionalization
with PEG. We bound the nanoparticles to three plasmids with different sizes (4–40 kpb). Vector
internalization was evaluated by confocal and electronic microscopy. Its transfection efficacy was
studied by fluorescence microscopy and flow cytometry. The application of the resulting vector in
gene therapy was evaluated indirectly using ganciclovir in HeLa cells transfected to express the
herpes virus thymidine kinase.
Results: An appropriate ratio between the nitrogen from the PEI and the phosphorous from the
phosphate groups of the DNA, together with a reduced size and an elevated electrokinetic poten-
tial, are responsible for an increased nanoparticle internalization and enhanced protein expression
when carrying plasmids of up to 40 kbp (plasmid size close to the limit of theDNA‐carrying capacity
of viral vectors). Compared to a commercial transfection reagent, an equal or even higher
expression of reporter genes (on HeLa andHek293t) and a suicide effect on HeLa cells transfected
with the herpes virus thymidine kinase genewere observedwhenusing this novel nanoparticulated
vector.
Conclusions: Nonviral vectors based on gold nanoparticles covalently coupled with PEG and
PEI can be used as efficient transfection reagents showing expression levels that are the same or
greater than those obtained with commercially available lipoplexes.
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Nanoparticle‐mediated transfection is characterized by a reduced
immunogenicity and a low production cost, as well as an easy and scal-
able synthesis process compared to the highly efficient viral vectors
(i.e. adenovirus, retrovirus, etc.). Endosomal escape, oligonucleotide
protection and efficient condensation, and intracellular unpacking are
the main drawbacks to overcome when designing nanoparticulatedo contributed equally to this
wileyonlinelibrary.com/journal/jgtransfection reagents. Not only nanoparticle diffusion, but also sedi-
mentation influences cellular uptake, which represents a very impor-
tant parameter to consider when carrying out in vitro studies.1
However, cellular uptake depends mainly on the oligonucleotide load-
ing on the surface of the nanoparticulated carrier.2 Gilleron et al.3
demonstrated in vitro and in vivo that only a small fraction of the small
interfering RNAs (siRNAs) was able to escape from the endosomes into
the cytosol, when using lipid nanoparticles as short interfering siRNA
delivery vectors. This gene delivery efficiency can be improved by pro-
moting endosomal escape and by protecting the oligonucleotide from
intra‐ and extracellular degradation. Drugs, peptides, lipids and cationicCopyright © 2017 John Wiley & Sons, Ltd.m 1 of 12
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mote this endosomal escape.4 The protection of the oligonucleotide of
interest against enzymatic nuclease degradation can be carried out by
encapsulation inside the nanoparticulated system5 or by means of
layer‐by‐layer assembly of alternate polyelectrolytes on the surface
of the nanoparticles together with the plasmid or siRNA.6 Finally,
direct covalent coupling of the oligonucleotide to the nanoparticle
reduces the susceptibility to nuclease degradation when the bond does
not impair the oligonucleotide biological activity.7 Those benefits have
supported several clinical trials using nanoparticles transporting
plamids8 and siRNAs9 suppressing or silencing genes involved in
cancer proliferation.
Rosi et al.7 demonstrated that, with the same amount of antisense
oligonucleotide transported, gold nanoparticles can outperform the
silencing efficiency in terms of protein percent knockdown compared
to different commercially available transfection reagents with no signs
of cytotoxicity at the doses tested. Lee et al.10 described the gene
silencing efficiency of cysteamine modified gold nanoparticles deco-
rated with polyethylenimine (PEI) and targeted using hyaluronic acid
with luciferase‐specific siRNA and vascular endothelial growth fac-
tor‐specific siRNA in the presence of 50 vol % serum to simulate
in vivo conditions. Under those conditions, a 70% reduction of the vas-
cular endothelial growth factor mRNA level was measured for the
nanoparticulated vector, whereas only a 20% reduction was observed
for the commercial lipofectamine used as control. Simultaneous co‐
delivery of siRNA and plasmidic DNA for knockdown and expression
was demonstrated by Bishop et al.11 using polymer‐coated (by layer‐
by‐layer) gold nanoparticles with a superior performance compared
to commercially available transfection reagents at the same dosage in
human brain cancer cells.
However, even with higher transfer efficiency, strategies designed
to improve the oligonucleotide penetration and lower cytotoxicity are
highly desirable. Accordingly, strategies using copolymers based on PEI
and polyethylene glycol (PEG) and linked with cell penetrating peptides
(i.e. trans‐activating transcriptional activator TAT) have been widely
used as transfection reagents.12 For those polyplexes, appropriate
sizes (between 50 and 75 nm) and PEI nitrogen to DNA phosphates
ratios (30–40) are critical to achieving a high transfection efficiency.12
The use of PEI and PEG as transfection reagents has also been previ-
ously combined with magnetic nanoparticles. The conjugation of PEI
to nanoparticles favors DNA sedimentation and cellular uptake and
enhances the transfection efficiency.13 In this regard, Stephen et al.14
have recently reported the use of chitosan‐PEG grafted with catechol
functionalized with cationic PEI on the surface of magnetic nanoparti-
cles. However, the transfection efficiency was reduced when PEG was
used to reduce the cytotoxicity of the transfection reagent. In addition,
PEG and PEI have also been grafted on the surface of carbon nano-
tubes15 and graphene16 to silence target gene expression via RNA
interference, taking advantage of the improved solubility provided by
the PEG.
In general, PEG reduces nonspecific interactions with plasma pro-
teins and nanoparticle‐cell internalization with a consequent reduction
in the transfection efficacy. Many PEG de‐shielding strategies have
been implemented to release the plasmid in vivo under the intracellular
reductive conditions.17,18 Williams et al.19 demonstrated in vivo thatneither the covalent coupling, nor the electrostatic interaction of gold
nanoparticles to PEI/PEG increased the transfection efficiency and
protein expression compared to the levels achieved with the PEI/PEG
polyplexes alone. It was postulated that the electrostatic interaction
was not sufficiently stable during the delivery and, for the case of
the covalently grafted PEI/PEG, a low nanoparticle to PEI/PEG ratio
might be responsible for such a reduced transfection efficiency.
In the present study, we describe a transfection reagent based on
gold nanoparticles and PEG/PEI in which the transfection efficiency
levels reached are equivalent or even superior under some conditions
to commercially available transfection reagents using 3000, 4700 and
up to 40000 bp plasmids, with the later being close to the limit of
the DNA‐carrying capacity of viral vectors.20 Therefore, using those
novel nanoparticles, not only electrostatic attraction, but also sedimen-
tation21 can aid in moving the DNA to the cell wall.2 | MATERIALS AND METHODS
2.1 | Nanoparticle synthesis and characterization
Au‐PEI nanoparticles were synthesized using PEI branched
(aproximately 25 kDa; Sigma‐Aldrich, St Louis, MO, USA) as a reduc-
tant and stabilizer. Briefly, 1 mL of a 0.5 × 10−3 M PEI solution was
added to 19 mL of a solution of 50 mg L−1 of HAuCl4 at room temper-
ature under vigorous stirring. The resulting Au‐PEI nanoparticles were
dialyzed (50 kDa cut‐off) against distilled water to eliminate the
unbounded PEI. Those nanoparticles were subsequently bound to
PEG using an excess of monofunctional poly(ethylene glycol)methyl‐
ether‐thiol (800 Da MW; Sigma‐Aldrich). Any excess of unbound
PEG was removed by dialysis (14 kDa cut‐off).
Preliminary electron microscopy observations were carried out in
the Advanced Microscopy Laboratory of the Aragon Institute of
Nanoscience, University of Zaragoza, using aT20‐FEI microscope with
a LaB6 electron source fitted with a ‘SuperTwin®’ objective lens (FEI,
Hillsboro, OR, USA), allowing a point‐to‐point resolution of 2.4 Å.
Aberration corrected scanning transmission electron microscopy
images were acquired using a high angle annular dark field detector
in a FEI XFEG TITAN electron microscope (FEI, Hillsboro, OR, USA)
operated at 300 kV equipped with a CETCOR Cs‐probe corrector
(CEOS Company, Heidelberg, Germany) allowing formation of an elec-
tron probe of 0.08 nm. The geometric aberrations of the probe‐
forming system were controlled to allow a beam convergence of 24.7
mrad half angle to be elected. Phosphotungstic acid was used to visu-
alize PEG and PEI functionalization. The zeta potential and the particle‐
size distribution were measured by dynamic light scattering (DLS) at
pH 7 in a Brookhaven 90 Plus equipment using ZetaPals (Brookhaven
Instruments Corp., Holtsville, NY, USA). Also, ultraviolet (UV)‐visible
spectroscopy (V670; Jasco, Easton, MD, USA) was used for the nano-
particle extinction spectrum evaluation. The bond between PEI, Au and
PEG was studied by Fourier transform infrared spectroscopy. Nitrogen
(from PEI) to phosphorous (from phosphate groups in the DNA) ratios
were calculated using X‐ray photoelectron spectroscopy (XPS) using
an Axis Supra (Kratos Analytical, Manchester, UK). A monochromatic
Al Kα X‐ray radiation (hν = 1486.6 eV) was used as an excitation
ENCABO‐BERZOSA ET AL. 3 of 12source at 15 kV and 15 mA. The peaks analysis was developed by
CasaXPS (Casa Software Ltd, Teignmouth, UK). In this analysis, the
core level P 2p3/2 centered at 133.4 eV was attributed to the phos-
phate groups in the DNA in agreement with a previous study.222.2 | NPs/DNA complex formation and agarose gel
electrophoresis retention assay
Au‐PEI and Au‐PEI‐PEG nanoparticles were complexed with DNA at
different μg NPs μg−1 DNA weight (w/w) ratios. The amount of DNA
was kept constant (1 μg) and the nanoparticle mass was varied from
10 to 50 μg in a final volume of 50 μL. The complexes were incubated
for 30 min at room temperature. The DNA binding ability of the NPs
was evaluated using the agarose gel electrophoresis retention assay.
The loading buffer was mixed with the complexes before adding them
into 1% agarose gel containing SYBR Safe stain. After running the gel
at 60 V for 40 min, the migration of plasmidic DNA was visualized in
a UV chamber (ChemiDoc RXS; Bio‐Rad, Hercules, CA, USA). More-
over, the DNA/NPs binding ability was analyzed measuring the surface
charge of the complexes by DLS in Brookhaven 90 Plus apparatus.
To study the DNA protection capacity of the nanoparticles, the
Au‐PEI or Au‐PEI‐PEG/DNA complexes were incubated with NotI
and XhoI restriction enzymes for 1 h at 37°C. The resulting digestion
was added into a 1% agarose gel containing SYBR Safe stain and ran
at 60 V for 40 min. The migration of the fragment was visualized in a
UV chamber (ChemiDoc RXS; Bio‐Rad).2.3 | AFM analysis
Atomic Force Microscope (AFM) measurements were made in liquid
phase by the Quantitative Nanomechanical Measurement Peakforce
intermittent contact technique, in a Multimode 8 (Bruker Co., Billerica,
MA, USA). The applied force was 1 nN and the tip used was a commer-
cial tip (SNL model, type – C; Bruker) with a hardness around 0.5 N m−1.2.4 | Cell culture and nanoparticle cytotoxicity
evaluation
HeLa and Hek293t cells were obtained from the Cancer Research UK
Culture Collection (London, UK). Both types of cells were cultured in
Dulbecco's modified Eagle's medium (DMEM) with 10% fetal bovine
serum (Gibco, Gaithersburg, MD, USA), 1% penicillin/streptomycin
and 1% amphotericin and maintained at 37°C in a 5% CO2‐humidified
incubator. For the cytotoxicity experiments, HeLa and Hek293t cells
were seeded onto 96 multi‐well plates at 5 × 103 or 1 × 104 cells per
well, respectively. The toxicity of the different vectors (Au‐PEI and
Au‐PEI‐PEG nanoparticles) was evaluated using the AlamarBlue assay
(Thermo Fisher, Waltham, MA, USA) after 24 h of incubation for differ-
ent nanoparticle concentrations (12.5 μg mL−1 to 100 μg mL−1).2.5 | Confocal microscopy
To assess the intracellular trafficking of the reporter gene pEGFP,
confocal microscopy was used. The pEGFP was labeled with Laber
IT® μArray Cy5 (Mirus, Madison, WI, USA) in accordance with the
manufacturer's instructions. For the DNA internalization assay, cellswere cultured on sterile cover slips at 2 × 104 cells per dish before run-
ning confocal microscopy analysis. For that purpose, 1 μg of labeled‐
pEGFP was complexed with 20 or 30 μg of Au‐PEI‐PEG nanoparticles
or with 3 μL of Lipofectamine 2000 in 50 μL of DMEM. The complexes
were incubated with cells for 4 h. Afterwards, cells were washed with
PBS twice and fixed with 4% para‐formaldehyde for 20 min, followed
by staining with phalloidin 488 to label the actin fibers and the cell
nucleus with 4′,6‐diamidino‐2‐phenylindole. The intracellular localiza-
tion of the resulting complexes inside the cells was confirmed using an
Compact TypeOil FV10i confocal microscope (Olympus, Tokyo, Japan).2.6 | Transfection assays
Three different plasmids were conjugated to Au‐PEI‐PEG nanoparticles:
pEGFP, pΔdTL and pTK. pEGFP‐N1 (Clontech, Palo Alto, CA, USA) is a
4.7 kbp plasmid that encodes the green fluorescence protein under
the cytomegalovirus promoter. The ΔdtL was kindly provided by
Dr. Ramón Alemany (Bellvitge Biomedical Research Institute, Barcelona,
Spain). This 41.9 kbp plasmid not only has the inactivated genome of an
oncolytic virus, but also encodes a green fluorescence protein.23 pTK
was provided by Dr. Jon Schoorlmmer (Fundación Araid, Zaragoza,
Spain). This 5 kbp expression vector encodes the herpes simplex virus
thymidine kinase gene under the control of the thymidine kinase pro-
moter. EGFP and ΔdtL transfection efficiencies were evaluated by fluo-
rescence microscopy, whereas EGFP expression was also quantified by
flow cytometry. In addition, TK expression was indirectly measured
studying the ganciclovir (GCV) cytotoxic effect in transfected cells
because it is the prodrug that activates the suicide effect of TK. In all
cases, the ratio between NPs and DNA was 20:1 and 30:1 w/w.
To carry out the fluorescence microscopy experiments, cells were
seeded onto 96 multi‐well plates at the densities noted above. Then,
125 or 250 ng of pEGFP or pΔdTL was added to each well. First, the
Au‐PEI‐PEG nanoparticles/DNA (20:1 and 30:1 w/w) or Lipofecta-
mine/DNA complexes were incubated with HeLa or Hek293t cells
for 24 or 48 h. In the case of Lipofectamine, the culture medium was
changed 4 h after its addition, and the Lipofectamine/DNA ratio was
3:1 (v/w), as normally indicated for our cell types. The green fluores-
cence was visualized using an IX81 inverted fluorescence microscope
(Olympus). For the evaluation of the transfection efficiency using
cytometry, cells were seeded onto six multi‐well plates (1 × 105 cells
per well). The transfection efficiency was evaluated by flow cytometry
using a FACSAria separator cytometer (BD Biosciences, San Jose, CA,
USA) under 488 nm laser excitation. Cells were incubated with Au‐
PEI‐PEG nanoparticles/DNA or Lipofectamine/DNA complexes for
24 or 48 h. Also in this case, the medium of the cells treated with
Lipofectamine was changed after 4 h. At the desired time points, cells
were harvested and EGFP expression quantified.
To follow‐up the transfection effects with the plasmid encoding
the thymidine kinase gene, cells were incubated with the complexes
for 24 h. Then, DMEM containing 1 mg mL−1 of GCV (Sigma‐Aldrich)
was added to the cellular cultures. GCV is a pro‐drug that exerts
antiproliferative effects in cells that express the thymidine kinase gene.
Both types of cells (HeLa and Hek293t) were incubated with this GCV
medium for 72 h. Afterwards, an AlamarBlue assay was performed to
analyze the cellular viability.
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To study the intracellular localization of Au‐PEI and Au‐PEI‐PEG nano-
particles, HeLa cells were seeded at a 1 × 106 cell per plate density onto
a t75 flask and cultured for 24 h. At that time point, a dispersion of
DMEM containing 10 μg mL−1 of Au‐PEI or Au‐PEI‐PEG nanoparticles
in a final volumeof 10mLwas added to the culture. Cellswere incubated
with this dispersion for 24 h. After that, cells were washed twice with
PBS and trypsinized. The cellular pellet was fixed with 2.5% glutaralde-
hyde for 1 h and washed again twice with PBS. A post‐fixation was per-
formed for 1.5 h in 1% osmium tetroxide at room temperature. The
samples were washed several times before their dehydration in graded
seriesof ethanol (30, 50,70,95and100vol%) andpropyleneoxide.Both
samples were then embedded in Durcupan (Sigma‐Aldrich). Sections
with a thickness of approximately 60 nm were mounted on nickel grids
before their examination by aT20‐FEI microscope and by aTitan Cube
60–300 TEM (FEI) operating in high angle annular dark field mode.FIGURE 1 Au‐PEI and Au‐PEI‐PEG nanoparticle characterization. (A) Au‐P
STEM‐HAADF image (bottom). The PEG corona is visible because of
Lipofectamine and the nanoparticles incubated with pEGFP. Zeta potentia
potential was measured at pH 7 in distilled water. PEI‐gold nanoparticles
potential of +30.26 ± 0.8 mV and +26 ± 2.5 mV, respectively2.8 | Statistical analysis
Results are expressed as the mean ± SD. Statistical analysis was per-
formed with STATA software (StataCorp, College Station, TX, USA).
Student's t‐test was used to assess statistical differences (p < 0.05)
between groups with normal distribution and Kruskal–Wallis
(p < 0.05) between groups with a non‐normal distribution.3 | RESULTS
3.1 | Nanoparticle synthesis and characterization
Figure 1 describes the morphology of the nanoparticulated gene
carriers in the present study. DLS measurements revealed a hydrody-
namic size distribution centered at 11.1 ± 2 nm and histograms
retrieved from the transmission electron microscopy (TEM) sizeEI (left) and Au‐PEG‐PEI (right) nanoparticles TEM images (above) and
the phosphotungstic acid staining (right). (B) DLS analysis. Size of
l of the Au‐PEI‐PEG nanoparticles after GFP plasmid coupling. The Z
and PEG‐PEI gold nanoparticles both without plasmids have a zeta
ENCABO‐BERZOSA ET AL. 5 of 12analysis on dried samples (11,3 ± 2 nm) corroborated those sizes. The
polycrystalline structure of the nanocrystals can be observed in the
high‐resolution transmission electron microscopy images. Also, an
organic halo around the nanoparticles is indicative of the presence of
the polymeric PEI and PEG corona. The colloidal Au‐PEI‐PEG nanopar-
ticles in water show a maximum UV–visible extinction peak at around
520 nm (see Supporting information, Figure S1). This absorption is
characteristic of the localized surface plasmon resonance peak of
spherical gold nanocrystals as a result of the gold interband transitions
reached when the value of the real part of the dielectric function of the
particle material equals two times the dielectric constant of the solvent
(water).24 The high extinction at low wavelengths observed is caused
by the scattering of the samples. Zeta potential analysis revealed a
positive charge for the colloidal Au‐PEI‐PEG nanoparticles, and an
electrokinetic potential that was reduced after plasmid DNA (pEGFP)
grafting but still positive to be able to electrostatically interact with
the negatively charged cell surface glycoproteins. A reduced size
(approximately five‐fold less) and higher zeta potential (approximately
three‐fold more) was observed for the Au‐PEI‐PEG nanoparticles com-
pared to Lipofectamine 2000 after DNA coupling.
Fourier transform infrared spectroscopy (FTIR) analysis (see
Supporting information, Figure S1) was performed to evaluate the suc-
cessful covalent coupling between the SH‐PEG and the gold nanopar-
ticles and also to corroborate the presence of the amino groups
introduced by the PEI. SH‐PEG exhibits the S–H stretching vibrational
mode appearing at around 2557 cm−1. As expected, subsequent to itsFIGURE 2 Biological characterization of Au‐PEI and Au‐PEI‐PEG nanoparti
plasmid ratios (w/w), the amount of DNA was kept constant and the amoun
evaluation of Au‐PEI an Au‐PEI‐PEG nanoparticles in HeLa and Hek293t
relative to an untreated control for which 100% viability was setreaction with Au‐PEI nanoparticles, the S–H bond stretching vibra-
tional band completely disappeared, which indicated the formation of
the S–Au bond.25 This S–Au interaction is partially covalent (approxi-
mately 35%) and mostly electrostatic (approximately 65%).26 N–H
bending and C–N stretching modes were observed near 1594 and
1120 cm−1, respectively. CH2 bending modes and C–C stretching
modes were also observed at 1454 and 1047 cm−1, respectively.
Two N–H stretching modes were detected for the primary amine
group near 3355 and 3277 cm−1, and an overtone band near
3180 cm−1 was also present. The characteristic C–H stretching modes
were observed between 3000 and 2700 cm−1, with the most intense
band being centered near 2805 cm−1. For Au‐PEI nanoparticles, the
relative intensity of the C–N stretching mode was diminished relative
to that of the C–C stretching modes.
XPS analysis (see Supporting information, Table S1) also revealed
the presence of phosphorus on the Au‐PEI‐PEG nanoparticles incu-
bated with the DNA, revealing a N/P from phosphate ratio of 40.6
(see Supporting information, Table S1). This high ratio is a guarantee
of a successful transfection in agreement with previous studies.12,13,273.2 | DNA‐nanoparticle complex formation and
cytotoxicity evaluation
The agarose gel electrophoresis assay demonstrated nanoparticle/
DNA electrostatic complexation (Figure 2). A constant amount of dif-
ferent plasmid DNA was complexed with Au‐PEI or Au‐PEI‐PEGcles. Agarose gel electrophoresis for different Au‐PEI and Au‐PEI‐PEG/
t of nanoparticles was increased from 10 to 50 μg (above). Cytotoxicity
cells using the AlamarBlue assay (bottom). The toxicity was calculated
6 of 12 ENCABO‐BERZOSA ET AL.nanoparticles at different ratios of 50:1, 40:1, 30:1, 20:1 and 10:1
(nanoparticles:DNA). Maximum fluorescence signals were detected
for the 20:1 and 30:1 samples, whereas, at higher nanoparticle load-
ings, the band was not clearly observed, probably caused by the fluo-
rescence quenching by nanoparticle agglomeration in agreement with
the previous literature27. To demonstrate the presence of the DNA,
we use, as control, a 1:1 ratio of NPs:DNA (see Supporting information,
Figure S2). In that large DNA excess, the genetic material was not
totally bound to the NPs and a free DNA band was observed. Three
different plasmids of different number of base pairs (3000, 4700 and
up to 40000 kbp) were successfully complexed by the Au‐PEI‐PEG
nanoparticles and no signs of plasmid fragmentation were observed.
Subcytotoxic doses for the Au‐PEI and Au‐PEI‐PEG nanoparticles
were investigated on different cell lines (HeLa andHek293t), evaluating
the resazurin colorimetric change in response to the cellular metabolism
(Figure2). Following the recommendations of the ISO10993–5 inwhich
viabilities higher than 70% are not considered cytotoxic, we proposed
the in vitro use of Au‐PEI‐PEG nanoparticles at doses up to 50 μg mL−1
on Hek293t cells and up to 25 μg mL−1 on HeLa cells. Our resultsFIGURE 3 pEGFP transfection evaluation by fluorescence microscopy in H
excitation/emission. All the images were acquired with the × 10 objective
microscope IX81 (Olympus). Scale = 200 μm. Cells not incubated with an
Lipofectamine/pEGFP complexes were used as a positive controlindicated that doses below 12.5 μg mL−1 could potentially be used for
transfectionapplicationson thosecell lineswhenusing justAu‐PEInano-
particles.Clearly, PEGylation reducedPEI cytotoxicity inagreementwith
the literature,28 probably caused by a reduced cell internalization.
We also analyzed the DNA protection from degradation using a
gel retardation assay. Naked DNA showed degradation after treatment
with the XhoI and NotI restriction enzymes (see Supporting informa-
tion, Figure S3). By contrast, no significant loss of plasmid integrity
was observed for the nanoparticulated complexes, indicative of a suc-
cessful DNA condensation and protection in the polymeric nanoparti-
cle corona. DNA condensation was also corroborated by AFM (see
Supporting information, Figure S4) where a slight nanoparticle size
increase was observed for the Au‐PEI‐PEG nanoparticles after DNA
coupling and no free DNA was observed.3.3 | Transfection efficiency
We observed how GFP expression was qualitatively enhanced when
using both Au‐PEI‐PEG 20:1 and 30:1 (w/w) transfection reagentseLa and Hek293t cells. GFP fluorescence was evaluated at 488/520 nm
24 h after the addition of the complexes in a fluorescence inverted
y vector were used as negative control, whereas cells incubated with
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HeLa and Hek293t cell lines. Bright field images show that the mor-
phology of the cell lines was not altered by the presence of the nano-
particles. HeLa cells remained elongated, growing adherently with
epithelial morphology. Hek293t cells also remained unaltered, showing
an epithelial adherent morphology.
Figure 4 shows the fluorescence quantification by flow cytometry
from cells expressing the gene for green fluorescent protein (GFP)
using the nanoparticles and the commercial Lipofectamine 2000. Sim-
ilar results were obtained 24 h after transfection but, 48 h later, the
green fluorescence intensity was higher (p < 0.05) when using Au‐
PEI‐PEG nanoparticles compared to the control. The percentage of
GFP positive cells 48 h after the addition of the complexes was
approximately a 15% higher for the 20:1 ratio than for the Lipofecta-
mine‐based control and, for the 30:1 ratio, the percentage of GFP pos-
itive cells 48 h after the addition of the complexes was a 20% higher
than that obtained for the control.
A successful transfection was even achieved using the Au‐PEI‐
PEG nanoparticles as gene carriers of a 40000 bp plasmid (Figure 5).FIGURE 4 Fluorescence quantification by flow cytometry in HeLa and He
Statistically significant differences are labelled with an asterisk (*) (p < 0.05
incubated whit any vector were used as negative controlQualitatively, a higher transfection was achieved when using the
gold‐based nanocarriers. The transfection efficiency of large plasmids
is limited by the slow transit through the intracellular vesicles by
molecular crowding and small plasmids are usually diffusing faster
towards the nuclei.29,30
Because one of the main purposes of this strategy would be the
use of those NPs as vectors for gene therapy, we performed a classical
approach of suicide gene therapy mediated by the herpes simplex virus
thymidine kinase gene triggered by the prodrug ganciclovir. The gene
product phosphorylates the nontoxic GCV into GCV triphosphate,
which is incorporated into DNA in replicating cells, inhibiting DNA syn-
thesis and resulting in cell death.31 Figure 6 shows the enhanced trans-
gene efficient delivery when using the Au‐PEI‐PEG nanoparticles
compared to the use of the commercial formulation.
Intracellular trafficking was monitored using Cy5 labeled‐pEGFP
complexed with either Au‐PEI‐PEG nanoparticles or with Lipofecta-
mine 2000. As can be seen in Figure 7, after 4 h of incubation, com-
plexes were visible in the cytoplasm of the HeLa cells. The presence
of Lipofectamine/Cy5‐DNA complexes in the extracellular matrixk293t cells. The cytometry graphs show the GFP positive cells at 48 h.
). Positive control represents the use of Lipofectamine 2000. Cells not
FIGURE 5 pΔdTL transfection evaluation by fluorescence microscopy on Hek293t cells. The images were taken in a fluorescence inverted
microscope IX81 (Olympus). All the images were acquired with the × 10 objective 24 h after the addition of the complexes. In these cases, two
amounts of DNA were tested: 125 and 250 μg per well. Cells not incubated with any vector were used as a negative control, whereas cells
incubated with Lipofectamine 2000/pΔdTL complexes were used as a positive control
FIGURE 6 Cell viability using the thymidine kinase suicide gene under
the presence of GCV in HeLa cells. Phosphorilated GCV is able to
mediate the cell death at the doses studied. At the maximum
nanoparticle concentration, the high presence of Au‐PEI‐PEG
nanoparticles promote some death in the absence of GCV
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those observed when using the nanoparticulated gene carriers. The
orthogonal projections of the confocal images clearly show that some
labeled plasmids are located inside of the nuclei of the cells. The inter-
nalization of types of nanoparticles was also evaluated by high‐resolu-
tion transmission electron microscopy in HeLa cells. Figure 8 shows
the intracellular distribution of both types of nanoparticles inside the
cell cytosol. After 24 h of incubation, the nanoparticles wereaccumulated forming aggregates within intracellular vesicles without
reaching the cellular nucleus.4 | DISCUSSION
The transfection efficiency of nanoparticulated carriers can be
improved when combining an adequate electrokinetic potential, which
is able to electrostatically bind condensed DNA, with appropriate
gene‐vector dispersion and reduced agglomeration in the culture
media. PEI provides the surface charge needed for a successful trans-
fection as a result of its large buffering and endosomolytic ability and
PEG provides reduced unspecific adsorption and steric hindrance.
However, this PEI buffering ability and consequent change in the
endosomal pH is still a matter of debate32 and, most likely, its degrada-
tive action on the pH‐dependent endosomal compartment is responsi-
ble for the DNA release. Despite the successful transfection efficiency
of PEI, this cationic macromolecule acts as an apoptotic agent
disrupting the plasma membrane and altering the mitochondrial mem-
brane.33 As noted above, PEG has been introduced in PEI‐based vec-
tors to improve their solubility and to reduce their cytotoxicity but
with the main drawback of reducing the efficiency compared to that
achieved with the non‐PEGylated vector. The reduction in the cyto-
toxicity induced by the PEG is a result of its mitigation ability with
respect to the charge‐induced toxicity.14 This charge reduction
decreases the PEI buffering ability and also the successive washing
steps that follow to anchor PEG on the PEI‐based vector and
FIGURE 7 Internalization complexes evaluation by confocal microscopy. Intracellular trafficking of fluorescently (Cy5) labeled GFP plasmid bound
to either Lipofectamine or Au‐PEI‐PEG nanoparticles after 4 h of incubation. HeLa cells were fixed and visualized by confocal microscopy. Actin
fibers are shown in green and nuclei in cyan. The labelled plasmid DNA is shown in blue. Scale = 200 μm
ENCABO‐BERZOSA ET AL. 9 of 12participate in removing unbound PEI, which contributes to an efficient
gene expression.34 We clearly demonstrate (Figure 3).that PEG
reduces the PEI cytotoxicity probably caused by a reduction in the
negative charge considering that the electrokinetic potential of Au‐
PEI in water was +30.4 ± 0.8 mV and, after PEG grafting, the Au‐PEI‐
PEG nanoparticles showed a zeta potential of +26.2 ± 2.4 mV
(Figure 1). Enzymatic degradation is not responsible for a successful
gene transfer carried out by the nanoparticulated systems. We
observed that no significant loss of plasmid integrity was observed
after treating the nanoconjugated plasmids with restriction enzymes.
This is an indication that just PEI is a successful reagent to condense
plasmid DNA and protect it from degradation in the cytosol by achiev-
ing a more stable form with longer retention times than free DNA.35 It
has been postulated that PEI offers a steric and/or electrostatic barrier
to the diffusion of the restriction enzyme towards the protected
DNA.36 The different transfection levels achieved for the two cell linestested might be attributed to the different cell‐specific intracellular
barriers for the plasmid to overcome, as well as to the different tran-
scription efficiencies and consequent protein expression. It has been
reported that Hek293t cells exhibit the highest level of PEI‐mediated
GFP transfection, with 50–80% of cells showing protein expression.37
The gene expression levels obtained on HeLa cells were lower than
those obtained with Hek293t cells (Figures 3 and 4), which can be
attributed to the higher cytotoxicity of the Au‐PEI‐PEG nanoparticles
on the HeLa cells at the same doses (Figure 3). In addition, the 293 t
cell line contains the SV40 Large T‐antigen, which allows for episomal
replication of transfected plasmids containing SV40, as for the pEGFP
used in the present study.29 For that reason, the amplification product
might have a larger temporal expression in the Hek293t cell line.
Lukacs et al.38 demonstrated that plasmid DNA with sizes above
250 bp remains almost immobile in the cytoplasm because of molecu-
lar crowding; however, PEI has demonstrated efficient transfection of
FIGURE 8 Internalization nanoparticle evaluation by TEM. Intracellular internalization of Au‐PEI (above) and Au‐PEI‐PEG (bottom) nanoparticles
evaluated in high angle annular dark field mode. HeLa cells were incubated with Au‐PEI (above) or Au‐PEI‐PEG (bottom) for 24 h, the arrows
indicate the presence of the nanoparticles and their intracellular presence within vesicles. The presence of gold was confirmed in both cases by
energy‐dispersive X‐ray analysis
10 of 12 ENCABO‐BERZOSA ET AL.large plasmids, being able to unpack and release the DNA, which then
diffuses to the nuclei. Large plasmid DNA (52.5 kbp) resulted in an
unsuccessful transfection efficiency when using lipoplexes because
of the incipient colloidal instability related to the size and morphology
of the polyplex invariant, irrespective of the plasmid size.30 Viral vec-
tors have been used linked to PEI to enhance transfection efficiency
when using ‘large’ plasmids. In this regard, 12‐kpb plasmids have been
linked to PEI and to an adenovirus for a successful transfection of
human primary myoblasts.39 In the present study, we demonstrated
how, qualitatively, a superior gene expression was achieved when
using Au‐PEI‐PEG nanoparticles compared to the use of the commer-
cial lipoplexe carrying a 40 kbp plasmid. This efficiency difference
might be attributed to the PEG ability in retarding endosomal escape,
as reported previously.40
Particle size affects gene expression and a reduced gene vector
agglomeration in the culture media favors DNA internalization. Large
agglomerates sediment and interact easily with the cellular membrane;
however, larger agglomerates are excluded from the endocytic route
and are usually internalized following macropinocytosis in which the
internalized cargo is stored in the lysosomal compartment.41
Therefore, we propose that the lack of large agglomerates with sizes
above 200 nm (which is the optical resolution of the confocal
microscope used) are responsible for a successful transfection
efficiency for our Au‐PEI‐PEG nanocarriers compared to the
Lipofectamine 2000 reagent where clear plasmid agglomerates were
observed in the culture media (Figure 7).
Compared to the commercial transfection reagent, the reduced
cytotoxicity of Au‐PEI‐PEG nanoparticles, together with their sedi-
mentation ability on the culture cells and their reduced size, areresponsible for the high levels of transgene expression observed. In
addition, gold might potentially provide a dual function, being not only
a gene carrier, but also a well known contrast agent in different medi-
cal imaging technologies, including optical coherence tomography,42
computed tomography,43 photoacoustic tomography,44 etc.5 | CONCLUSIONS
Gold nanoparticles can be employed as nonviral vectors for gene
expression using PEI as a surface functional agent. PEI condensates
and protects the carried plasmid from enzymatic degradation. The
PEGylation of those nanoparticles by covalent coupling reduces the
PEI cytotoxicity, and also enhances nanoparticle dispersion in culture
media. Different plasmids with a different number of pair bases can
be transfected using this vector and plasmids of up to 40 kpb can be
transfected with a superior performance compared to that obtained
with commercially available lipoplexes. Not only reporter genes, but
also a superior suicide effect in cells transfected with the herpes virus
thymidine kinase gene mediated by ganciclovir was observed using the
nanoparticulated vector.ACKNOWLEDGEMENTS
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